lomustine has been researched along with Genetic Predisposition in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morabito, F | 1 |
Hohaus, S | 1 |
Mammi, C | 1 |
Marcheselli, L | 1 |
Gentile, M | 1 |
Merli, F | 1 |
Montanini, A | 1 |
Stelitano, C | 1 |
La Sala, A | 1 |
Scalone, R | 1 |
Voso, MT | 1 |
Luminari, S | 1 |
Iannitto, E | 1 |
Gobbi, P | 1 |
Federico, M | 1 |
Walker, C | 2 |
Haylock, B | 2 |
Husband, D | 2 |
Joyce, KA | 2 |
Fildes, D | 2 |
Jenkinson, MD | 2 |
Smith, T | 2 |
Broome, J | 2 |
du Plessis, DG | 2 |
Warnke, PC | 2 |
Kopitzki, K | 1 |
Prosser, J | 1 |
Vinjamuri, S | 1 |
1 trial available for lomustine and Genetic Predisposition
Article | Year |
---|---|
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carbopl | 2012 |
2 other studies available for lomustine and Genetic Predisposition
Article | Year |
---|---|
Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Case-Control Studies; | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, | 2006 |